Cantargia Receives Capital Injection And Attracts New Board Members
STOCKHOLM--(BUSINESS WIRE)--Cantargia, a private biopharmaceutical company developing therapeutics for the treatment of leukemia, announces the conclusion of the first step in their financial plan and reinforces the board.
Help employers find you! Check out all the jobs and post your resume.